The Science Behind VPC's Approach

One Disease.
One Treatment.

Spinal cord injury, traumatic brain injury, severe concussion, and stroke look like different events — but they all trigger the same severe inflammatory disease in the central nervous system. Understanding this disease is the key to treating it.

What happens after neurotrauma

  • A spinal cord injury, TBI, concussion, or stroke causes immediate physical damage — hemorrhages, tissue death (necrosis), and the destruction of myelin, the protective sheath around nerve fibers. This initial damage is traumatic but it's only the beginning.

  • Within about three days of the injury, the body's immune response kicks in. Macrophages — the immune system's cleanup cells — flood the injury site to clear dead tissue and damaged myelin. But in the central nervous system, this process goes wrong. The macrophages become overactivated, releasing large quantities of inflammatory factors that cause destruction beyond the original injury.

  • Whether the initial event was a motorcycle accident, a fall, a blast injury, or a blocked blood vessel in the brain, the inflammatory disease that follows is the same. The severity and location differ, but the mechanism — macrophage-driven destruction and vascular damage — is identical. This is the insight Dr. Kwiecien's 35+ years of research revealed.

  • The inflammation doesn't just destroy tissue directly. It damages blood vessels in the spinal cord surrounding the injury. These damaged vessels leak excess fluid into the tissue — a condition called vasogenic edema. This swelling compresses otherwise healthy spinal cord tissue and causes paralysis, even in areas not directly damaged by the original injury.

  • The spinal cord does have natural mechanisms to resolve inflammation — primarily driven by astrocytes, which gradually reduce macrophage numbers starting around week 3. But these mechanisms are overwhelmed by the severity of the inflammation. Small numbers of macrophages and swelling persist for 16 weeks or longer after injury.

  • Most existing approaches focus on the acute event — stabilizing the spine, reducing immediate swelling with steroids, surgical decompression. These are necessary, but they don't address the inflammatory disease that begins days later and persists for months. By the time the acute phase is managed, the real destructive process is already underway and untreated.

  • Without intervention targeting the inflammatory disease, two things happen: the inflammation progressively destroys additional spinal cord tissue beyond the original injury, and persistent vasogenic edema prevents the surviving tissue from functioning. Both contribute to permanent paralysis and disability.

900,000+ SCI cases worldwide annually

$400B+ unmet global market

0 approved treatments targeting the inflammatory disease